Oracle Just Dropped 10% in a Month. Executed Perfectly, It’s “a Multiple of Where It Is Today,” per Gil Luria

Oracle shares fell about 10% over the past month, amid an AI infrastructure selloff that hit CoreWeave and Nvidia. Oracle raised $20B of capped capital, ended a reported Tencent chip-leasing deal, and expects positive free cash flow in 2H FY2028 on a $664B backlog.

Original reporting
Published Nov 18, 2026, 9:38 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 18, 2026, 10:06 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Oracle Just Dropped 10% in a Month. Executed Perfectly, It’s “a Multiple of Where It Is Today,” per Gil Luria — source image
Decision brief

The 30-second read

$ORCLBearishMed
01

Why it matters

The immediate impact is likely negative pressure on ORCL due to dilution and added debt, but the long‑term outlook hinges on the ability to convert a massive backlog into cash.

02

Market read

First‑time disclosure of a $20 B capital raise executed in a single day, a material event for a large‑cap tech stock.

03

What to watch

Oracle's $664 B backlog and OpenAI partnership may provide future cash‑flow upside that offsets short‑term dilution concerns.

Relevance 7/10Novelty 8/10Timing: pre‑market today

Background

Oracle's stock fell 10% over the past month amid an AI infrastructure sell‑off. The company announced a $20 B cap on new capital raises through FY2030 and then fully utilized it on Nov 2, issuing new shares and notes.

Company-level read

Ticker impact

$ORCLBearishHigh confidence
Context

Oracle disclosed it used its entire $20 billion capital‑raise cap in a single day, issuing 86.2 M new shares and $10 B of notes.

Expected impact

potential near‑term downside as investors price in dilution and cash‑burn risk

Evidence & confidence

First‑report of a $20 B raise executed at once is material; dilution and debt increase typically depress share price until cash‑flow benefits materialize.

Market effects

AI‑infrastructure sector may see broader pressure as peers like CoreWeave and Nvidia also face sell‑offs.

U.S. tech market could see modest pullback amid heightened dilution concerns.

Limited to investors tracking large‑cap tech valuations and AI spend trends.

Counterpoint

The capital raise could be seen as a vote of confidence in long‑term growth, offering a buying opportunity at a discounted price.

Key entities

  • Oracle

    U.S. listed software and cloud services provider (ORCL).

Related articles

$ORCLMed

Java4Shell: AI found a critical Java flaw, and Oracle patched it

Security firm Calif disclosed a critical flaw (CVE-2026-114938) in OpenJDK, affecting various distributions like Amazon Corretto and Oracle Java SE. Oracle patched it in its November update. The flaw, found using AI, allows unauthenticated code execution on x86-64 processors. Calif scored it 9.2, Oracle 8.1. No exploits reported yet.

$NVDAMedAI 8/10

AI stocks rally as Nvidia outlook calms demand fears

Nvidia's stronger-than-expected revenue forecast of $130 billion for Q4, up from analysts' estimates of $125.25 billion, boosted shares by 3.5% in premarket trading. This reassured investors about AI demand and drove gains in AI-related stocks like CoreWeave, Nebius Group, and data center companies. Broader chip and tech stocks also rose, with AMD, Broadcom, and Intel gaining. The AI trade faces regulatory concerns and upcoming tests like Anthropic's public offering.

$ORCLMed

Oracle $17 Billion VA Contract Boost Negotiated Quickly by Email

Oracle's contract with the VA for a new electronic health records system expanded to $27B from $10B after email negotiations. CEO Mike Sicilia will testify before Congress amid concerns over cost overruns and delays. The system is operational in about 10% of VA hospitals, with completion expected by 2031. Lawmakers question Oracle's financial commitment and long-term execution plans.

$ORCLMed

Oracle Stock Falls 4% as HSBC Sells $300M Loan in Mid-80s

Oracle (ORCL) stock fell 4% as HSBC sold $300M of Project Jupiter data center debt at a discount, raising concerns about financing costs. Oracle traded at $114.34, down from $119.09. HSBC sold its portion of the $18B financing package at mid-80s cents on the dollar. Oracle issued a force majeure notice due to construction delays.